This might highlight another difference between the early and late stages of tumor growth, as autocrine SDF1/CXCR4 signaling has been shown to be involved in proliferation of various glioma cell lines (for review see (Gagliardi et al., 2014)). Here, CXCL12 is linked to central nervous system cancer.